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http://dx.doi.org/10.1016/j.kjms.201Abstract The aim of this study was to explore memory deficits and psychopathology and their
relationships with P300 in drug-naı¨ve patients with schizophrenia. The Positive and Negative
Syndrome Scale (PANSS) and the Wechsler Memory ScaledRevised were administered. Auditory
event-related potentials elicited by an oddball paradigm were obtained. After controlling for
age, sex, the results showed a statistically significant negative correlation between the total
PANSS score and P300 amplitude at the parietal position (r Z 0.66, p < 0.05). Moreover, vi-
sual memory was significantly positively correlated with P300 amplitude at the parietal posi-
tion (r Z 0.67, p < 0.05). After controlling for the duration of illness, the above
correlations remained statistically significant. The correlation between P300 and the severity
of psychopathology was reconfirmed in drug-naı¨ve patients with schizophrenia. A possible
contribution of memory decompensation in P300 among drug-naı¨ve patients with schizophreniahave no conflicts of interest relevant to this article.
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The auditory P300 induced by the classical oddball paradigm
has been used as an evaluation of cognitive processes, such as
attention allocation and activation of immediate memory, in
many studies among healthy individuals [1]. Also, P300 is
thought to be an index of brain activity, linked to the updating
of task-relevant information in the working memory [2].
P300 is also correlated with schizophrenia in terms of
multiple fields, which could be predictors of cognitive
function decline and symptom exacerbation. However,
P300 is easily influenced by multiple factors, including
medication effects. A short-term P300 follow-up in patients
with schizophrenia receiving antipsychotic treatment
revealed that the P300 amplitudes were increased [3,4].
Some studies showed limited changes in the P300 amplitude
even after antipsychotics use [5]. A study focused on the
differences between treated schizophrenics and drug-naı¨ve
ones, revealing that the P300 latency was prolonged in
previously treated schizophrenics compared with neuro-
leptic-naı¨ve schizophrenics and normal controls [6]. Wang
et al [4] reported a significant interaction between the
duration of untreated psychosis and the medication effect
in P300 amplitude: a significant P300 recovery was found in
untreated psychosis of a short duration but not of a long
duration. Moreover, a reduced P300 amplitude was found at
the parietal position in nonmedicated prodromal patients,
first-episode and chronic patients with schizophrenia [7],
and clinical high-risk groups [8], which indicated a corre-
lation between the duration of illness and the P300 ampli-
tudes. A longer duration of illness would alter P300
presentation, which may contribute to the latency prolon-
gation as other studies demonstrated [9].
Therefore, schizophrenia is a complex disorder, and its
pathophysiology is best understood through findings from
drug-naı¨ve or first-episode schizophrenia patients, mainly
because confounding factors such as the duration of illness,
neuroleptics, and/or hospitalization among chronic pa-
tients are difficult to disentangle from the disease process.
For the above reasons, drug-free patients with schizo-
phrenia might reveal more information about the changes
in P300 and its original condition.
Bramon et al’s [10] meta-analysis and Galderisi et al’s
[11] review confirm a reduced P300 amplitude in patients
with schizophrenia compared with healthy controls. The
data from 11 P300 drug-free studies also showed significant
amplitude reductions and latency delays in unmedicated
patients [10]. Less evidence supports a latency change of
P300 in schizophrenia [5]. Therefore, researchers are
continually working to explore the possibilities of P300 as a
biological marker to detect the clinical progression of
schizophrenia, as well as using brain imaging studies.
From the psychopathology point of view, reports of as-
sociations between P300 amplitude or latency and clinicalsymptoms are inconsistent. Some researchers found no
significant correlations [12]. Relationships between P300
amplitude and positive symptoms [13], negative symptoms
[14], or total psychopathology have been reported but the
above studies were not under medication-free episode.
Few studies have focused on the relationship between
event-related potentials (ERPs) and Positive and Negative
Syndrome Scale (PANSS) scores in drug-naı¨ve patients with
schizophrenia [15], but one study showed that no rela-
tionship existed between Brief Psychiatric Rating Scale
score, Scale for the Assessment of Negative Symptoms
score, and Scale for the Positive Symptoms score and P300
alterations in young-onset schizophrenic patients, some of
whom (7/36) were drug-naı¨ve cases [16].
Saykin et al [17] also found that first-episode schizo-
phrenia patients had generalized neurocognitive impair-
ment, particularly in verbal memory and learning. In
addition, they concluded that verbal memory, as a primary
neuropsychological deficit, is present early in the course of
schizophrenia [17]. A few later studies recognized visual
deficits in medication-free schizophrenic patients [18]. Vi-
sual P300 induced by the classical oddball paradigm, as
compared with auditory P300, is not consistently reported
to be impaired in patients with schizophrenia. However,
problems in visual memory or the visual pathway assessed
by a combination of ERP and neurocognitive function tests
among patients with schizophrenia have been reported
[19]. Considering the variant change profile in cognitive
functions among schizophrenic patients, we surmise that
the correlates of P300 might be different from those in
healthy controls.
To conclude, the association between psychopathology/
cognitive function and P300 has been demonstrated in
studies mentioned above. Exploring the association may
provide an opportunity for clinicians to understand the
neurophysiological correlates of clinical manifestations and
progressions. Moreover, neuroleptics treatment may
become a confounding factor to influence their associations
[3,4]. Therefore, we chose drug-naı¨ve patients with
schizophrenia to examine these associations in avoidance
of medication effects. The aims of this study were to
examine: (1) the relationship between the psychopathology
severity and ERP recordings, (2) the relationship between
memory performance and P300 recordings, and (3) the
changes in the amplitudes and latencies of P300 in drug-
naı¨ve schizophrenic patients.Methods
Participants
Fourteen patients were included (8 males, 6 females); the
average age was 25.2  6.1 years (range 18e37 years).
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deviation (SD) Z 5.58, median Z 1.99, inter quartile
range Z 5.28]. The educational level was 13.07 years on
average. All patients met the Diagnostic and Statistical
Manual of Mental Disorders 4th EditiondRevised criteria
for the diagnosis of schizophrenia disorder. The PANSS was
administered. Thirteen of 14 patients were in the first-
episode stage when they were recruited into our study.
All participants were drug-naı¨ve and right-handed. The
definition of “drug-naı¨ve patients” required that the pa-
tients never had any psychotropic medications prescribed
and our clinic was their first contact with psychiatric
services. All participants had no obvious history of phys-
ical systemic illness, and other comorbid psychiatric or
neurological illnesses. They were not mentally retarded,
pregnant, at risk of suicide, or experiencing unstable
clinical psychiatric symptoms. The control group consist-
ing of 14 individuals was interviewed by senior psychia-
trists who had been practicing for more than 10 years
using the Chinese version of the Mini International
Neuropsychiatric Interview, to ensure that the partici-
pants were free of any Axis I or Axis II psychiatric disor-
ders. These participants were physically healthy and had
no history of alcohol or other substance abuse or depen-
dence. Any participant who had been taking psychotropic
medications, including antipsychotics or antidepressants,
was excluded.
Prior to when any procedure was performed, written
informed consent was obtained from each participant after
a complete explanation has been given. The Ethical Com-
mittee for Human Research at the National Cheng Kung
University Hospital, Tainan, Taiwan approved the study
protocol.Event-related potentials
ERPs were recorded using an auditory oddball paradigm,
based on methods that have been established previously
[20]. Electroencephalograms (EEGs) were recorded with a
recording apparatus (SYNAMPS; Compumedics Neuroscan,
El Paso, TX, USA). Recordings were performed using an
electrocap in a sound-attenuated and electrically shielded
environment with an acoustic Celotex board. Auditory
stimuli were delivered binaurally through headphones, and
the interstimulus interval was from 1 second to 2 seconds.
Random deviant tones (2000 Hz; possibility, 0.2) that
differed from the nontarget events (1000 Hz; possibility,
0.8) in pitch were established. Participants would look at
the “þ” target on the screen, ignoring the frequent tones,
and press the button as soon as possible when they iden-
tified one of the target tones. Thirty-one scalp electrode
sites according to the international 10e20 systems were
used to collect digitally averaged signals. P300 potentials
were recorded from the electrodes at the frontal (Fz),
central (Cz), and parietal (Pz) positions referenced to
linked mastoids. The P300 amplitude was measured relative
to the mean of the 100 m/s prestimulus baseline, with peak
latency defined as the period associated with the maximum
positive amplitude during the 200e400 m/s interval after
the stimulus. Eye movements were recorded by an elec-
trode lateral to both eyes, which was near the outer regionsof the canthus. The EEG and eye channels (NuAmps, Com-
pumedics Neuroscan) were appropriately amplified (EEG
gain Z 1000) and filtered (band pass Z 0.1e30 Hz). Both
the amplitudes and the latencies of P300 were recorded by
technicians. Participants who received less than 20
accepted trials for the target were excluded. Electroocu-
lographies of trials with amplitudes over 50 mV were also
omitted in our field.
Memory measurement
The Wechsler Memory ScaledRevised (WMS-R) battery was
used [21]. There are 13 items included in the tests of the
WMS-R, which represent different facets of memory. All the
tests mentioned above were administered by trained psy-
chologists. The average score of the WMS-R was about 100,
and the standard deviation (SD) for the WMS-R in the gen-
eral population is 15. Cross-validation has been performed
in previous studies [22].
Statistical analysis
The data were analyzed using SPSS version 17 (SPSS Inc.,
Chicago, IL, USA). Means and SDs were calculated for the
descriptive analysis of the participants and their controls.
Because the sample size was small, the ManneWhitney U
test was used to examine the group differences. The
adjusted correlations between P300 and memory scores as
well as P300 and the severity of psychopathology were
assessed using partial correlation, controlling for sex and
age in the first model and then controlling for sex, age, and
duration of illness in the second example. Statistical sig-
nificance was established at p < 0.05.
Results
A summary of the demographic data, memory performance,
and psychopathology of the participants, including the
drug-naı¨ve schizophrenic patients and healthy controls, is
given in Table 1. There was a significantly lower memory
performance in all domains of the WMS-R in the patient
group. There were no significant differences in the ampli-
tude and the latency of P300 between the patients with
schizophrenia and the control group.
Table 2 shows that in the first model, after adjusting for
sex and age, the total score of the PANSS was highly
inversely correlated with the amplitude of P300 at Pz
(r Z 0.66, p < 0.05). Visual memory was positively
correlated with the amplitude of P300 at Pz (r Z 0.67,
p < 0.05), but not with latency. General memory was
positively correlated with the P300 amplitude at Pz
(r Z 0.66, p < 0.05). In the second model, the duration of
illness added as the third covariate, the significances of
correlation between P300 and psychopathology as well as
memory functions still existed (total PANSS: r Z 0.72,
p < 0.05; visual memory: r Z 0.70, p < 0.05; general
memory: r Z 0.78, p < 0.05). No statistically significant
correlation between verbal memory and P300 was found.
On the contrary, no statistical significance was observed in
the healthy control group in terms of the correlation be-
tween P300 and all the storage batteries.
Table 1 Demographic data, P300, neuropsychological performance, and psychopathology of the patients with schizophrenia
and the control group.
Drug-naı¨ve
schizophrenic
patients
(n Z 14)
Controls
(n Z 14)
Statistical test
Mean (SD) Mean (SD) ManneWhitney U p
Age (y) 25.19 (6.10) 26.35 (7.51) 0.41 0.68
Sex (male/female) 8/6 8/6 d d
Educational level (y) 13.07 (1.90) 14.29 (1.33) 1.86 0.06
ERP P300
Amplitude
Parietal 8.98 (3.34) 8.28 (2.34) 1.06 0.29
Central 8.28 (3.38) 7.06 (3.72) 1.29 0.20
Frontal 6.24 (2.84) 6.98 (3.99) 0.55 0.58
Latency
Parietal 334.21 (30.47) 334.00 (27.95) 0.21 0.84
Central 331.64 (29.83) 330.00 (29.79) 0.21 0.84
Frontal 328.64 (28.67) 330.86 (27.80) 0.18 0.85
WMS-R
Verbal memory 79.00 (13.13) 104.57 (14.04) 3.65 <0.01
Visual memory 97.62 (19.25) 115.43 (16.11) 2.31 0.02
General memory 82.67 (13.72) 109.36 (15.79) 3.42 <0.01
Attention/concentration 92.62 (17.49) 115.21 (11.81) 3.14 <0.01
Delayed-recall memory 90.92 (16.81) 112.29 (18.39) 2.40 0.02
PANSS 89.85 (43.98)
PANSS_p 23.77 (8.75)
PANSS_n 21.08 (11.29)
PANSS_g 39.85 (26.43)
PANSS_s 7.23 (6.33)
ERP Z event-related potential; PANSS Z positive and negative syndrome scale of schizophrenia (p Z positive, n Z negative,
g Z general psychopathology, s Z supplementary items for the aggression risk profile); WMS-R Z Weschler Memory ScaledRevised.
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In this study, the diminution of the Pz amplitude was
correlated with memory in the drug-naı¨ve schizophrenic
patients, which was supported by previous studies [23].
Also, the amplitude of P300 at Pz and Cz was correlated
with the PANSS scores after adjusting for sex, age, and
duration of illness, which corresponded with the studies
mentioned above [24]. However, the association betweenTable 2 Partial correlation, controlling for age and sex, of
latencies).
Central position
Amplitude Latency
Patients with
schizophrenia
Healthy
controls
Patients with
schizophrenia
H
c
PANSS 0.47 d 0.25
WMS-R
Verbal Memory 0.28 0.31 0.08
Visual Memory 0.47 0.57 0.14
General Memory 0.39 0.42 0.03
*p < 0.05.
ERP Z event-related potential; PANSS Z positive and negative s
ScaledRevised.P300 and cognitive functions or psychopathology is not
conclusive [25,26]. A possible explanation of the inconsis-
tent findings may be related to the “state or trait” hy-
pothesis, which could be inferred that P300 may be a
biological marker in the acute stage [8]. Medication may be
another confounding factor, which may alter both the
PANSS score and the ERP measurements. Some studies have
shown that the P300 amplitudes may increase after psy-
chotic symptoms improve, with or without medicationthe neuropsychological tests and the ERP (amplitudes and
Parietal position
Amplitude Latency
ealthy
ontrols
Patients with
schizophrenia
Healthy
controls
Patients with
schizophrenia
Healthy
controls
d 0.66* d 0.27 d
0.01 0.54 0.26 0.05 0.22
0.06 0.67* 0.38 0.14 0.16
0.03 0.66* 0.32 0.01 0.21
yndrome scale of schizophrenia; WMS-R Z Weschler Memory
P300 and memory in drug-naı¨ve psychosis 137treatment [3,24], which could be regarded as being in
support of the above explanation.
Second, we also found a correlation between visual
memory and the P300 amplitude, focused on the Pz. The
visual memory defects in patient with schizophrenia have
been well studied by means of different psychological
batteries [27e29]. One of the possible explanations of the
defects might be related to attention [7,30,31]. Another
possible explanation can be derived from the Default Model
Network (DMN), which may be associated with a reduction
in normal task-induced deactivation within the DMN, based
on findings that activity in key DMN regions persists inap-
propriately into task periods [32,33]. The DMN is defined as
the whole mental activation focused on stimulus-
independent thought (“mind-wandering”), and may alter
neurophysiological responses and cognitive deficits in
schizophrenia [32e34]. Furthermore, two networks of brain
areas carry out different attention functions. One system is
involved in preparing and applying goal-directed (top-
down) selection for stimuli and responses. This system is
also modulated by the detection of stimuli. The other sys-
tem is not involved in top-down selection, but is specialized
for the detection of behaviorally relevant stimuli, particu-
larly when they are salient or unexpected. This network,
located in the ventral frontal area, works as a “circuit
breaker” for the dorsal system, directing attention to
salient events, and is activated when individuals are not
involved in task-oriented activities [35]. We speculate that
the compensatory cognitive functions or DMN would be
activated while patients with schizophrenia are undergoing
neuropsychological assessment. Thus, the cognitive corre-
lates of P300 in schizophrenia would be altered, and
different from those in healthy controls.
Previous studies also showed that activations in patients
with schizophrenia were mainly localized to the visual and
insular cortices [32], which are all included in the dorsal
attention system. This might also partially explain the
compensatory mechanism in schizophrenic patients, in
which the dorsal attention systems were compensated for
the executive network in schizophrenia [36]. Thus, visual
memory was utilized for additional top-down orienting,
derived from the dorsal attention system, to maintain focus
on the task in our study [35].
Our findings also showed no significant correlation be-
tween verbal memory and P300, which has been reported in
some studies [37,38]. A possible explanation was that ver-
bal memory is not significantly impaired in first-onset, drug-
naı¨ve patients. Some evidence also supports the hypothesis
mentioned above: first-onset patients with schizophrenia
showed no difference in ERP and Mismatch Negativity with
healthy control groups as compared with chronic schizo-
phrenic patients [39,40]. Another meta-analysis also
revealed a normal Mismatch Negativity in terms of fre-
quency and duration in first-episode schizophrenia
compared with recent onset or chronic schizophrenia [41].
The correlation between a nonsignificant reduction in the
P300 amplitude and verbal memory in the present study
may also be explained in the beginning of the deterioration
of psychopathologies, but further studies are needed to
demonstrate this finding.
Another interesting finding in our study was that there
were no significant differences between the drug-naı¨vepatients with schizophrenia and the healthy control group
when viewing the amplitudes or latencies of P300. Some
previous studies have demonstrated similar results [42]. A
possible explanation might be that drug-naı¨ve patients with
schizophrenia in this study have a relatively preserved
intact neuroanatomical structure [43] (in view of our pa-
tient group, which was of a young age and a relatively fair
educational level), which would lead to less P300 differ-
ences. The results merit further investigation with larger
sample sizes in the future.
The limitations of our studies were as follows. (1) The
sample sizes were small; thus correlations found in this
study should be interpreted carefully. (2) In accordance
with medical ethics, we were only able to enroll patients
who were at lower risk of symptom exacerbation during the
short time in which no medication was given. Selection bias
may exist. (3) This was the cross-sectional study. Longitu-
dinal follow-up may be designed to examine the changes in
P300 and its associations with the psychopathologies and
memory functions.Acknowledgments
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